Page 3 of lupin

Trump tariff, pharma stocks surge, Nifty Pharma Index, US-India trade,

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

Pharma stocks surge as Trump’s tariff exemption boosts sector morale. Dive into this bullish trend today!

April 3, 2025 10:45 IST

stocks to watch, stock in news, stocks in news, stocks to know

Stocks To Watch: From Tariff impact on auto to Reliance Industries, HDFC, Bharat Dynamic, here’s a list of over 10 stocks in news today

Check out the top 10 Indian stocks in the spotlight amid market buzz and major sector developments. See which big…

April 3, 2025 07:04 IST

Three reasons why pharma stocks are falling today?

Pharma stocks are under significant selling pressure. Here is a detailed analysis on the top worries for the sector.

Updated: March 25, 2025 14:45 IST

Stocks To Watch: HCL Tech, Tata Power, HUL, and others

Stocks to watch today, March 10: GIFT Nifty was trading flat at 22,622, which indicates a muted start for domestic…

March 10, 2025 06:40 IST

Jefferies bets big on these 3 pharma stocks- Find out why

Jefferies backs Lupin, Zydus, and Biocon amid shifting US pharma market shares. Discover why these stocks are set to shine.

March 4, 2025 14:31 IST

Nuvama’s 4 Buy Recommendations in this down market

Nuvama recommends ‘Buy’ for SAIL, Berger Paints, Muthoot Finance, and Lupin. Explore these stocks’ growth potential amid market pressure!

February 13, 2025 12:28 IST

Lupin, Q3 results, quarter results, profit, revenue, EBITDA, sales, pharma company, healthcare sector

Lupin Q3 Results: Profit rises by 38.82% to Rs 858.86 crore, revenue up 10.97% YoY

Lupin recorded revenue from operations at Rs 5767.71 crore, up 10.97 per cent on-year. Revenue during the third quarter of…

February 12, 2025 11:38 IST

USFDA gives nod to Lupin’s generic formulation to treat eye issues

Loteprednol Etabonate Ophthalmic Gel, 0.38% (RLD Lotemax SM) had an estimated annual sale of USD 36 million in the U.S.…

January 9, 2025 17:14 IST

Lupin acquires Huminsulin from Lilly to enhance diabetes portfolio

There is a significant Indian population affected with diabetes for both Type 1 and Type 2 Diabetes Mellitus, where Insulin…

December 31, 2024 12:47 IST

USFDA gives nod to Lupin’s generic formulation to treat HIV infection

Emtricitabine and Tenofovir Alafenamide Tablets (RLD Descovy) had estimated annual sales of USD 3,556 million in the U.S.

December 19, 2024 08:33 IST

Lupin acquires three trademarks from Boehringer Ingelheim to strengthen diabetes portfolio in India

An estimated 80 million people above the age of 18 years have diabetes in India, in addition to 25 million…

December 16, 2024 08:03 IST

USFDA gives tentative approval to Lupin’s generic formulation to treat type 2 diabetes

The drug is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2…

November 29, 2024 12:59 IST

Lupin’s Humrahi diabetes support program expands to include heart health

This launch builds on the proven success of Humrahi, which has been instrumental in guiding patients toward better diabetes management,…

November 28, 2024 11:55 IST

Lupin launches drug to treat edema in United States

Bumetanide Injection USP (RLD Bumex) had an estimated annual sale of USD 20 million in the U.S, as per IQVIA…

November 20, 2024 11:57 IST

USFDA gives nod to Lupin’s generic formulation to treat ADHD symptoms

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, extroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release Capsules (RLD Adderall XR) had estimated annual sales of…

November 20, 2024 11:40 IST

Pharmaceuticals, Lupin Manufacturing Solutions, Disease area, CDMO market, pharma news, FE exclusive, healthcare news,

FE Exclusive | We are planning to expand our therapeutic footprint in high-demand disease areas: Dr. Abdelaziz Toumi, CEO, Lupin Manufacturing Solutions

Lupin entered into the CDMO business last year in June with the launch of its new subsidiary Lupin Manufacturing Solutions…

November 12, 2024 12:19 IST

USFDA gives nod to Lupin's generic formulation to treat eye diseases

USFDA grants tentative approval to Lupin’s generic formulation to treat HIV infection

Raltegravir Tablets USP, 600 mg (RLD Isentress HD) had an estimated annual sale of USD 36 million in the U.S.…

November 8, 2024 18:05 IST

Lupin share price today, Lupin share news

Lupin shares gain nearly 2% on strong Q2; Get your prescription for the stock

Lupin shares have shown strong growth, with a 3% return over the past three months and 30.65% over the last…

Updated: November 8, 2024 09:18 IST

Related News

FIIs defy sector gloom to buy this power stock: What’s Driving the 400% Profit Surge?

Not Adani, Not Tata: The one power stock FIIs are aggressively buying now

Meta’s $14 billion AI hire Alexandr Wang finds Mark Zuckerberg’s micromanagement ‘suffocating’: Report

H-1B visa, H-1B visa ban, H-1B visa program, temporary visa program, foreign worker program

US lawmaker proposes complete ban of H-1B visa program

Infographic showing top 10 Indian stocks with up to 61 percent upside including Eternal Zomato, Reliance Industries, and Meesho based on Jefferies and Motilal Oswal reports.

10 stocks with up to 61% upside – Top brokerage Buys this week

Maharashtra local body election result 2025 date and time: When and where to check civic poll results

Who was Basant Vivek Sagar? Late MIT alumnus remembered through scholarship fund

World News34 min ago

Basant Vivek Sagar, an Indian-born MIT alumnus and former NASA scientist, was honored posthumously with a donation to the MIT Class of 2011 Scholarship Fund. His self-taught journey to academic success serves as an inspiration, and his impact on the Institute and its people was recognized by the then-President of MIT.

View all shorts